Vivek Vallabhan

About Vivek Vallabhan

Experienced Marketing professional-17 yrs of diverse experience with Indian & Multi-national companies - P&L & People management since 2019 for Urology Business (Amphion: Turnover- 187 Cr). 4 Direct reportees (3 PM\'s, 1 APM)- New Product Launch Expertise: 1)Zytiga (Innovator)/Zelgor (Abiraterone acetate)- Defined mCRPC category in India for advanced prostate cancer patients where the only option was chemotherapy2)Degapride (Degarelix)- In high risk advanced prostate cancer patients 3)Mirago S (Mirabegron + Solifenacin)- In difficult to treat overactive bladder patients4)Enzyl (Enzalutamide)- In mCRPC patients in whom chemotherapy is still not indicated5)Contiflo-T (First FDC of Tamsulosin+ Tadalafil)- DCGI approved formulation)- In BPH patients with LUTS and underlying ED- Exposure to launching innovator and branded generics - Business/Speciality Exposure- Urology/Oncology/Nephrology/Biologics, Biosimilars- Shaped and executed Non comparable biologics strategy to counter biosimilar entry in India for (Avastin- Bevacizumab) with Roche Pharma as part of Pan Oncology Team

Experience

1. Deputy General Manager (Marketing)

   SUN PHARMA

   Apr 2023 — Present · Mumbai, IN

Education

• SIES College of Arts, Science and Commerce

  Bsc (Chemistry), Msc, ORGANIC CHEMISTRY

  2000 — 2005

• SIES College of Management Studies

  Master of Business Administration (MBA), Pharmaceutical Marketing, International marketing ,Sales&Distribution, Clinical research, IPR, OTC

  2005 — 2007

Skills

• Competitive Analysis
• Product Launch
• Pharmaceutical Sales
• Market Planning
• Marketing Management
• Market Analysis
• Market Research
• Sales Effectiveness
• Pharmaceutical Industry
• Pharmaceutics